Skip to Content

Join the 'Uptravi' group to help and get support from people like you.

Uptravi News

Uptravi Approved for Chronic Lung Disease

Posted 23 Dec 2015 by Drugs.com

TUESDAY, Dec. 22, 2015 – Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a disabling lung disease that often leads to death or the need for lung transplant. PAH is high blood pressure that affects arteries that connect the lungs and heart. It causes the heart to work harder, resulting in shortness of breath and limiting the ability to exercise, the FDA said Tuesday in a news release. Uptravi, among a class of drugs called oral IP prostacyclin receptor agonists, relaxes and opens blood vessels, easing the elevated pressure, the agency said. The drug was evaluated in clinical trials involving more than 1,150 adults with PAH. Trial participants who took the drug did so for an average of about a year and a half. The drug was found to limit worsening of the disease and reduce the need for hospitalization. ... Read more

Related support groups: Pulmonary Hypertension, Uptravi, Selexipag

FDA Approves Uptravi (selexipag) for Pulmonary Arterial Hypertension

Posted 23 Dec 2015 by Drugs.com

December 22, 2015 – On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation. “Uptravi offers an additional treatment option for patients with pulmonary arterial hypertension,” said Ellis Unger, M.D., director of the Office of Drug Evaluation I in the FDA’s Center for Drug Evaluation and Research. “The FDA supports continued efforts to provide new treatment options for rare diseases.” PAH is high blood pressure that occurs in the arteries that connect the heart to the lungs. It causes the right side of the heart to work harder than normal, which can lead to limitations on exercise ability and shortness of breath, among other more serious complications. Uptravi belongs to a class o ... Read more

Related support groups: Pulmonary Hypertension, Uptravi, Selexipag

Ask a Question

Further Information

Related Condition Support Groups

Pulmonary Hypertension

Uptravi Patient Information at Drugs.com